Analysts’ Viewpoint on the Smoking Cessation and Nicotine De-Addiction Market
Rise in demand for smoking cessation products, such as skin patches, lozenges, and gum, as well as prescription medicines is driving the global smoking cessation and nicotine de-addiction market. North America and Europe are highly mature markets for smoking cessation and nicotine de-addiction. Popularity of e-cigarettes is rising among teenagers across the globe. E-cigarettes help users quit the smoking habit. Key players are focusing on product innovation to gain revenue benefits. Asia Pacific is estimated to witness a significant demand for smoking cessation products during the forecast period.
Smoking cessation therapy lowers the risk of cancer and other serious health issues. Smoking cessation and nicotine de-addiction products include OTC products (with nicotine), prescription products, and prescription products (without nicotine). These products are used to help users quit smoking. Rise in awareness about counseling, behavior therapy, medicines, and nicotine-containing products, such as nicotine patches, gum, lozenges, inhalers, and nasal sprays, is expected to drive the global smoking cessation and nicotine de-addiction market.
According to the World Health Organization (WHO), tobacco kills more than 8 million people each year. More than 7 million of these deaths are the result of direct tobacco use, while around 1.2 million are the result of non-smokers being exposed to secondhand smoke. 80% of the world's 1.3 billion tobacco users reside in low- and middle-income countries where the burden of tobacco-related illness and death is the heaviest. In 2021, 65.3% of youth (middle and high school students) who used smoking cessation medication or products were seriously thinking about quitting the usage of all tobacco products.
Cigarette and tobacco addicts can be better treated with smoking cessation products. Smoking cessation medications and tobacco cessation tools comprise nicotine replacement therapy (NRT), electronic cigarettes, and therapeutic medication such as anti-depressants and nicotine receptor agonists that help in quitting smoking and preventing diseases caused due to smoking. Hence, rise in number of users who quit cigarettes due to the usage of quit-smoking products is a key factor driving the global smoking cessation and nicotine de-addiction market.
Rise in number of users preferring e-cigarettes is driving the smoking cessation and nicotine de-addiction market. E-cigarettes do not produce tar or carbon monoxide ‒ two of the most harmful elements in tobacco smoke. The liquid and vapor contain some harmful chemicals that can also be found in cigarette smoke; however, they are at much lower levels. The number of e-cigarette users increased from around 700,000 in 2012 to 3.6 million in 2019, falling to 3.2 million in 2020, and rising again to 3.6 million in 2021. Popularity of e-cigarettes is higher as they are safer than combustible cigarettes. E‐cigarettes can also help smokers quit combustible cigarettes. Consequently, rise in popularity of e-cigarettes over cigarettes among young users is driving the smoking cessation and nicotine de-addiction market.
According to the Foundation for a Smoke-Free World, based in the U.S., the total retail market for NRT and smoking cessation products stood at US$ 2.5 Bn in terms of value in 2020. NRT gum accounted for 51.4% share, while NRT lozenges held 21.3% share of the market in the same year. NRT patches accounted for 20.4% share, and NRT inhalers held 1.0% share. North America and Europe are the only regions that witnessed substantial sales for NRT products, accounting for 50.3% and 38.8% of total sales, respectively, in terms of value, in 2020.
NRT products include vaping products, heated tobacco, and tobacco-free oral nicotine. North America and Europe hold major share of the total demand for NRT products globally. Penetration of NRT products is low in countries in Asia Pacific compared to that in developed regions. Hence, Asia Pacific is likely to offer significant opportunities for key manufacturers of NRT products.
High Sales of Smoking Cessation and Nicotine De-Addiction Products through Offline Distribution Channel
In terms of distribution channel, the offline segment holds major value share of the global market. The online segment is estimated to grow at a notable CAGR during the forecast period. Users are preferring offline stores such as hospital pharmacies, local medical stores, and supermarkets due to the easy availability of a wide range of products. Users can also choose according to their preference.
In terms of value, North America leads the global smoking cessation and nicotine de-addiction market, followed by Europe and Asia Pacific. The U.S. is the largest smoking cessation and nicotine de-addiction market in the world and accounts for a prominent share in terms of value and volume. High share of the U.S. can be ascribed to the significantly high usage of e-cigarettes among teenagers in the country. Usage of e-cigarettes among high school students in the U.S. increased from 1.5% in 2011 to 19.6% in 2020.
Europe is also a prominent market for smoking cessation and nicotine de-addiction products globally. The U.K. is the second-largest smoking cessation and nicotine de-addiction market in the world, after the U.S. It is the largest smoking cessation and nicotine de-addiction market in Europe. Nicotine-containing OTC smoking cessation products are the most preferred nicotine replacement therapy (NRT) products in the U.K. Rise in awareness about smoking cessation benefits among the people and increase in number of smoking cessation programs are driving the market in Europe.
Detailed profiles of players in the smoking cessation and nicotine de-addiction market have been provided in the report to evaluate their financials, key product offerings, recent developments, and strategies. Majority of firms are spending significantly on comprehensive research and development activities. Expansion of product portfolios and mergers and acquisitions are prominent strategies adopted by key players.
Pfizer Inc., GlaxoSmithKline plc (GSK), Cipla Ltd., Johnson & Johnson (J&J), ITC Ltd., Takeda Pharmaceutical Company Ltd., Alkalon A/S, 22nd Century Group, Inc., Strides Pharma Science Ltd., and JUUL Labs, Inc are the key players operating in the global smoking cessation and nicotine de-addiction market.
|
Attribute |
Detail |
|
Market Size Value in 2021 (Base Year) |
US$ 10.54 Bn |
|
Market Forecast Value in 2031 |
US$ 27.84 Bn |
|
Growth Rate (CAGR) |
10.2% |
|
Forecast Period |
2022‒2031 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
Global qualitative analysis includes drivers, restraints, opportunities, key trends, upcoming key trends, Porter’s Five Forces analysis, value chain analysis, SWOT analysis, etc. Furthermore, at the regional level, qualitative analysis includes key trends, price trends, and key supplier analysis. |
|
Competition Landscape |
Market Player – Competition Dashboard and Revenue Share Analysis 2021 Company Profiles (Details – Company Overview, Sales Area/Geographical Presence, Revenue, COVID-19 Response, Strategy & Business Overview) |
|
Regions Covered |
|
|
Market Segmentation |
|
|
Companies Profile |
|
|
Customization Scope |
Available upon Request |
|
Pricing |
Available upon Request |
The smoking cessation and nicotine de-addiction market stood at US$ 10.54 Bn in 2021.
The smoking cessation and nicotine de-addiction market is expected to reach a value of US$ 27.84 Bn by 2031.
Rise in health awareness and number of users quitting smoking globally; and increase in usage of e-cigarettes across the world are key factors driving the market.
The e-cigarettes segment accounted for the prominent share of the smoking cessation and nicotine de-addiction market in 2021.
North America accounted for more than 30% share, in terms of value, of the global smoking cessation and nicotine de-addiction market in 2021.
Key players operating in the global smoking cessation and nicotine de-addiction market are Pfizer Inc., GlaxoSmithKline plc (GSK), Cipla Ltd., Johnson & Johnson (J&J), ITC Ltd., Takeda Pharmaceutical Company Ltd., Alkalon A/S, 22nd Century Group, Inc., Strides Pharma Science Ltd., and JUUL Labs, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions
3. Research Methodology
4. Executive Summary
5. Market Overview
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.2. Key Trends Analysis
5.2.1. Demand Side Analysis
5.2.2. Supply Side Analysis
5.3. Key Market Indicators
5.4. Porter’s Five Forces Analysis
5.5. Value Chain Analysis
5.6. Industry SWOT Analysis
5.7. Global Smoking Cessation and Nicotine De-Addiction Market Analysis, 2017‒2031
5.7.1. Market Value Projections (US$ Mn)
6. Global Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast, by Product Type
6.1. Global Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017‒2031
6.1.1. Product (with nicotine)
6.1.1.1. OTC Products
6.1.1.1.1. E-cigarettes
6.1.1.1.2. Nicotine Gums (NRT)
6.1.1.1.3. Nicotine Patches (NRT)
6.1.1.1.4. Nicotine Lozenges (NRT)
6.1.1.1.5. Nicotine Tablets (NRT)
6.1.1.2. Prescription Products
6.1.1.2.1. Nicotine Sprays (NRT)
6.1.1.2.2. Nicotine Inhalers (NRT)
6.1.2. Product (without nicotine)
6.1.2.1. Prescription Products
6.1.2.1.1. Zyban
6.1.2.1.2. Chantix
6.2. Incremental Opportunity, by Product Type
7. Global Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast, by Distribution Channel
7.1. Global Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn)t, By Distribution Channel, 2017‒2031
7.1.1. Online
7.1.2. Offline
7.2. Incremental Opportunity, by Distribution Channel
8. Global Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast, Region
8.1. Global Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Region, 2017‒2031
8.1.1. North America
8.1.2. Europe
8.1.3. Asia Pacific
8.1.4. Middle East & Africa
8.1.5. South America
8.2. Incremental Opportunity, by Region
9. North America Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
9.1. Regional Snapshot
9.2. Price Trend Analysis
9.2.1. Weighted Average Selling Price (US$)
9.3. Key Trends Analysis
9.3.1. Demand Side Analysis
9.3.2. Supply Side Analysis
9.4. COVID-19 Impact Analysis
9.5. Key Supplier Analysis
9.6. Consumer Buying Behavior Analysis
9.7. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017‒2031
9.7.1. Product (with nicotine)
9.7.1.1. OTC Products
9.7.1.1.1. E-cigarettes
9.7.1.1.2. Nicotine Gums (NRT)
9.7.1.1.3. Nicotine Patches (NRT)
9.7.1.1.4. Nicotine Lozenges (NRT)
9.7.1.1.5. Nicotine Tablets (NRT)
9.7.1.2. Prescription Products
9.7.1.2.1. Nicotine Sprays (NRT)
9.7.1.2.2. Nicotine Inhalers (NRT)
9.7.2. Product (without nicotine)
9.7.2.1. Prescription Products
9.7.2.1.1. Zyban
9.7.2.1.2. Chantix
9.8. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Distribution Channel, 2017‒2031
9.8.1. Online
9.8.2. Offline
9.9. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Country and Sub-region, 2017‒2031
9.9.1. U.S.
9.9.2. Canada
9.9.3. Rest of North America
9.10. Incremental Opportunity Analysis
10. Europe Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
10.1. Regional Snapshot
10.2. Price Trend Analysis
10.2.1. Weighted Average Selling Price (US$)
10.3. Key Trends Analysis
10.3.1. Demand Side Analysis
10.3.2. Supply Side Analysis
10.4. COVID-19 Impact Analysis
10.5. Key Supplier Analysis
10.6. Consumer Buying Behavior Analysis
10.7. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017‒2031
10.7.1. Product (with nicotine)
10.7.1.1. OTC Products
10.7.1.1.1. E-cigarettes
10.7.1.1.2. Nicotine Gums (NRT)
10.7.1.1.3. Nicotine Patches (NRT)
10.7.1.1.4. Nicotine Lozenges (NRT)
10.7.1.1.5. Nicotine Tablets (NRT)
10.7.1.2. Prescription Products
10.7.1.2.1. Nicotine Sprays (NRT)
10.7.1.2.2. Nicotine Inhalers (NRT)
10.7.2. Product (without nicotine)
10.7.2.1. Prescription Products
10.7.2.1.1. Zyban
10.7.2.1.2. Chantix
10.8. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn) Forecast, by Distribution Channel, 2017‒2031
10.8.1. Online
10.8.2. Offline
10.9. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Country and Sub-region, 2017‒2031
10.9.1. U.K.
10.9.2. Germany
10.9.3. France
10.9.4. Rest of Europe
10.10. Incremental Opportunity Analysis
11. Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
11.1. Regional Snapshot
11.2. Price Trend Analysis
11.2.1. Weighted Average Selling Price (US$)
11.3. Key Trends Analysis
11.3.1. Demand Side Analysis
11.3.2. Supply Side Analysis
11.4. COVID-19 Impact Analysis
11.5. Key Supplier Analysis
11.6. Consumer Buying Behavior Analysis
11.7. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017‒2031
11.7.1. Product (with nicotine)
11.7.1.1. OTC Products
11.7.1.1.1. E-cigarettes
11.7.1.1.2. Nicotine Gums (NRT)
11.7.1.1.3. Nicotine Patches (NRT)
11.7.1.1.4. Nicotine Lozenges (NRT)
11.7.1.1.5. Nicotine Tablets (NRT)
11.7.1.2. Prescription Products
11.7.1.2.1. Nicotine Sprays (NRT)
11.7.1.2.2. Nicotine Inhalers (NRT)
11.7.2. Product (without nicotine)
11.7.2.1. Prescription Products
11.7.2.1.1. Zyban
11.7.2.1.2. Chantix
11.8. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Distribution Channel, 2017‒2031
11.8.1. Online
11.8.2. Offline
11.9. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Country and Sub-region, 2017‒2031
11.9.1. China
11.9.2. India
11.9.3. Japan
11.9.4. Rest of Asia Pacific
11.10. Incremental Opportunity Analysis
12. Middle East & Africa Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
12.1. Regional Snapshot
12.2. Price Trend Analysis
12.2.1. Weighted Average Selling Price (US$)
12.3. Key Trends Analysis
12.3.1. Demand Side Analysis
12.3.2. Supply Side Analysis
12.4. COVID-19 Impact Analysis
12.5. Key Supplier Analysis
12.6. Consumer Buying Behavior Analysis
12.7. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017‒2031
12.7.1. Product (with nicotine)
12.7.1.1. OTC Products
12.7.1.1.1. E-cigarettes
12.7.1.1.2. Nicotine Gums (NRT)
12.7.1.1.3. Nicotine Patches (NRT)
12.7.1.1.4. Nicotine Lozenges (NRT)
12.7.1.1.5. Nicotine Tablets (NRT)
12.7.1.2. Prescription Products
12.7.1.2.1. Nicotine Sprays (NRT)
12.7.1.2.2. Nicotine Inhalers (NRT)
12.7.2. Product (without nicotine)
12.7.2.1. Prescription Products
12.7.2.1.1. Zyban
12.7.2.1.2. Chantix
12.8. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Distribution Channel, 2017‒2031
12.8.1. Online
12.8.2. Offline
12.9. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Country and Sub-region, 2017‒2031
12.9.1. GCC
12.9.2. South Africa
12.9.3. Rest of Middle East & Africa
12.10. Incremental Opportunity Analysis
13. South America Smoking Cessation and Nicotine De-Addiction Market Analysis and Forecast
13.1. Regional Snapshot
13.2. Price Trend Analysis
13.2.1. Weighted Average Selling Price (US$)
13.3. Key Trends Analysis
13.3.1. Demand Side Analysis
13.3.2. Supply Side Analysis
13.4. COVID-19 Impact Analysis
13.5. Key Supplier Analysis
13.6. Consumer Buying Behavior Analysis
13.7. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Product Type, 2017‒2031
13.7.1. Product (with nicotine)
13.7.1.1. OTC Products
13.7.1.1.1. E-cigarettes
13.7.1.1.2. Nicotine Gums (NRT)
13.7.1.1.3. Nicotine Patches (NRT)
13.7.1.1.4. Nicotine Lozenges (NRT)
13.7.1.1.5. Nicotine Tablets (NRT)
13.7.1.2. Prescription Products
13.7.1.2.1. Nicotine Sprays (NRT)
13.7.1.2.2. Nicotine Inhalers (NRT)
13.7.2. Product (without nicotine)
13.7.2.1. Prescription Products
13.7.2.1.1. Zyban
13.7.2.1.2. Chantix
13.8. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Distribution Channel, 2017‒2031
13.8.1. Online
13.8.2. Offline
13.9. Smoking Cessation and Nicotine De-Addiction Market Size (US$ Mn), by Country and Sub-region, 2017‒2031
13.9.1. Brazil
13.9.2. Rest of South America
13.10. Incremental Opportunity Analysis
14. Competition Landscape
14.1. Market Player – Competition Dashboard
14.2. Company Profiles (Details – Company Overview, Sales Area/Geographical Presence, Financial/Revenue, Strategy & Business Overview, Sales Channel Analysis, Size Portfolio)
14.2.1. Pfizer Inc.
14.2.1.1. Company Overview
14.2.1.2. Sales Area/Geographical Presence
14.2.1.3. Financial/Revenue
14.2.1.4. Strategy & Business Overview
14.2.1.5. Sales Channel Analysis
14.2.1.6. Size Portfolio
14.2.2. GlaxoSmithKline plc (GSK)
14.2.2.1. Company Overview
14.2.2.2. Sales Area/Geographical Presence
14.2.2.3. Financial/Revenue
14.2.2.4. Strategy & Business Overview
14.2.2.5. Sales Channel Analysis
14.2.2.6. Size Portfolio
14.2.3. Cipla Ltd.
14.2.3.1. Company Overview
14.2.3.2. Sales Area/Geographical Presence
14.2.3.3. Financial/Revenue
14.2.3.4. Strategy & Business Overview
14.2.3.5. Sales Channel Analysis
14.2.3.6. Size Portfolio
14.2.4. Johnson & Johnson (J&J)
14.2.4.1. Company Overview
14.2.4.2. Sales Area/Geographical Presence
14.2.4.3. Financial/Revenue
14.2.4.4. Strategy & Business Overview
14.2.4.5. Sales Channel Analysis
14.2.4.6. Size Portfolio
14.2.5. ITC Ltd.
14.2.5.1. Company Overview
14.2.5.2. Sales Area/Geographical Presence
14.2.5.3. Financial/Revenue
14.2.5.4. Strategy & Business Overview
14.2.5.5. Sales Channel Analysis
14.2.5.6. Size Portfolio
14.2.6. Takeda Pharmaceutical Company Ltd
14.2.6.1. Company Overview
14.2.6.2. Sales Area/Geographical Presence
14.2.6.3. Financial/Revenue
14.2.6.4. Strategy & Business Overview
14.2.6.5. Sales Channel Analysis
14.2.6.6. Size Portfolio
14.2.7. Alkalon A/S
14.2.7.1. Company Overview
14.2.7.2. Sales Area/Geographical Presence
14.2.7.3. Financial/Revenue
14.2.7.4. Strategy & Business Overview
14.2.7.5. Sales Channel Analysis
14.2.7.6. Size Portfolio
14.2.8. 22nd Century Group, Inc.
14.2.8.1. Company Overview
14.2.8.2. Sales Area/Geographical Presence
14.2.8.3. Financial/Revenue
14.2.8.4. Strategy & Business Overview
14.2.8.5. Sales Channel Analysis
14.2.8.6. Size Portfolio
14.2.9. Strides Pharma Science Ltd
14.2.9.1. Company Overview
14.2.9.2. Sales Area/Geographical Presence
14.2.9.3. Financial/Revenue
14.2.9.4. Strategy & Business Overview
14.2.9.5. Sales Channel Analysis
14.2.9.6. Size Portfolio
14.2.10. JUUL Labs, Inc.
14.2.10.1. Company Overview
14.2.10.2. Sales Area/Geographical Presence
14.2.10.3. Financial/Revenue
14.2.10.4. Strategy & Business Overview
14.2.10.5. Sales Channel Analysis
14.2.10.6. Size Portfolio
15. Key Takeaway
List of Tables
Table 1: Global Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017‒2031
Table 2: Global Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn,2017‒2031
Table 3: Global Smoking Cessation and Nicotine De-Addiction Market Value, by Region, US$ Mn, 2017‒2031
Table 4: North America Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017‒2031
Table 5: North America Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn,2017‒2031
Table 6: North America Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-Region, US$ Mn, 2017‒2031
Table 7: Europe Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017‒2031
Table 8: Europe Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn,2017‒2031
Table 9: Europe Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-Region, US$ Mn, 2017‒2031
Table 10: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017‒2031
Table 11: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn,2017‒2031
Table 12: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-Region, US$ Mn, 2017‒2031
Table 15: MEA Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017‒2031
Table 16: MEA Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn,2017‒2031
Table 17: MEA Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-Region, US$ Mn, 2017‒2031
Table 18: South America Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017‒2031
Table 19: South America Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn,2017‒2031
Table 20: South America Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-Region, US$ Mn, 2017‒2031
List of Figures
Figure 1: Global Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017‒2031
Figure 2: Global Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by product Type, 2022‒2031
Figure 3: Global Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn, 2017‒2031
Figure 4: Global Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Distribution Channel, 2022‒2031
Figure 5: Global Smoking Cessation and Nicotine De-Addiction Market Value, by Region, US$ Mn, 2017‒2031
Figure 6: Global Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Region,2022‒2031
Figure 7: North America Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017‒2031
Figure 8: North America Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by product Type, 2022‒2031
Figure 9: North America Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn, 2017‒2031
Figure 10: North America Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Distribution Channel, 2021‒2031
Figure 11: North America Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-region, US$ Mn, 2017‒2031
Figure 12: North America Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Country and Sub-region, 2022‒2031
Figure 13: Europe Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017‒2031
Figure 14: Europe Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by product Type, 2022‒2031
Figure 15: Europe Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn, 2017‒2031
Figure 16: Europe Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Distribution Channel, 2022‒2031
Figure 17: Europe Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-region, US$ Mn, 2017‒2031
Figure 18: Europe Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Country and Sub-region, 2022‒2031
Figure 19: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017‒2031
Figure 20: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by product Type, 2022‒2031
Figure 21: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn, 2017‒2031
Figure 22: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Distribution Channel, 2022‒2031
Figure 23: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-region, US$ Mn, 2017‒2031
Figure 24: Asia Pacific Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Country and Sub-region, 2022‒2031
Figure 25: MEA Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017‒2031
Figure 26: MEA Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Product Type, 2022‒2031
Figure 27: MEA Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn, 2017‒2031
Figure 28: MEA Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Distribution Channel, 2022‒2031
Figure 29: MEA Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-region, US$ Mn, 2017‒2031
Figure 30: MEA Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Country and Sub-region, 2022‒2031
Figure 31: South America Smoking Cessation and Nicotine De-Addiction Market Value, by product Type, US$ Mn, 2017‒2031
Figure 32: South America Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by product Type, 2022‒2031
Figure 33: South America Smoking Cessation and Nicotine De-Addiction Market Value, by Distribution Channel, US$ Mn, 2017‒2031
Figure 34: South America Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Distribution Channel, 2022‒2031
Figure 35: South America Smoking Cessation and Nicotine De-Addiction Market Value, by Country and Sub-region, US$ Mn, 2017‒2031
Figure 36: South America Smoking Cessation and Nicotine De-Addiction Market Incremental Opportunity, by Country and Sub-region, 2022‒2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Smoking Cessation and Nicotine De-Addiction Market Outlook 2031
